Anlotinib combined with induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A phase II study.
文献类型:期刊论文
作者 | Jiang, Feng; Chen, Xiaozhong; Liu, Tongxin; Qin, WeiFeng; Huang, Shuang; Cao, Caineng; Jin, Ting; Jin, Qifeng |
刊名 | JOURNAL OF CLINICAL ONCOLOGY |
出版日期 | 2022-06-01 |
卷号 | 40 |
ISSN号 | 0732-183X |
WOS研究方向 | Oncology |
语种 | 英语 |
出版者 | LIPPINCOTT WILLIAMS & WILKINS |
WOS记录号 | WOS:000863680303641 |
源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/129925] |
专题 | 中国科学院合肥物质科学研究院 |
作者单位 | Univ Chinese Acad Sci, Canc Hosp, Hangzhou, Peoples R China |
推荐引用方式 GB/T 7714 | Jiang, Feng,Chen, Xiaozhong,Liu, Tongxin,et al. Anlotinib combined with induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A phase II study.[J]. JOURNAL OF CLINICAL ONCOLOGY,2022,40. |
APA | Jiang, Feng.,Chen, Xiaozhong.,Liu, Tongxin.,Qin, WeiFeng.,Huang, Shuang.,...&Jin, Qifeng.(2022).Anlotinib combined with induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A phase II study..JOURNAL OF CLINICAL ONCOLOGY,40. |
MLA | Jiang, Feng,et al."Anlotinib combined with induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A phase II study.".JOURNAL OF CLINICAL ONCOLOGY 40(2022). |
入库方式: OAI收割
来源:合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。